Mads Krogsgaard T

Bio-Pharmaceuticals
Nova
Ireland

Biography

Mads Krogsgaard Thomsen joined Novo Nordisk in 1991 as head of Growth Hormone Research. Following that he directed Diabetes R&D and Global Drug Discovery, and in November 2000 he was appointed executive vice president and chief science officer. In this role, he is responsible for global drug and device research, development, medical affairs, regulatory and safety within Novo Nordisk.

Research Interest

Bio-Pharmaceuticals

Global Experts from Ireland

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America